Bioceres Crop Solutions (BIOX) EBITDA Margin (2017 - 2026)

Bioceres Crop Solutions has disclosed EBITDA Margin across 10 years of filings, most recently posting 1.57% for Q1 2026.

• In Q1 2026, EBITDA Margin fell 1973.0% year-over-year to 1.57%; the TTM figure through Mar 2026 stood at 0.29% (down 1734.0% YoY), while the FY2025 annual figure was 0.67%, down 1054.0% from the prior year.
• EBITDA Margin came in at 1.57% for Q1 2026 at Bioceres Crop Solutions, down from 10.21% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 73.33% in Q3 2023 to a low of 70.31% in Q2 2022.
• Average EBITDA Margin over 5 years is 11.73%, with a median of 12.19% recorded in 2022.
• Year-over-year, EBITDA Margin surged 12188 bps in 2023 and tumbled 5055 bps in 2024.
• Over 5 years, EBITDA Margin stood at 2.35% in 2022, then jumped by 219 bps to 7.48% in 2023, then soared by 94 bps to 14.53% in 2024, then fell by 30 bps to 10.21% in 2025, then plunged by 115 bps to 1.57% in 2026.
• Per Business Quant data, the three most recent EBITDA Margin figures were 1.57% in Q1 2026, 10.21% in Q4 2025, and 9.31% in Q3 2025.